Probability of induction and stabilization of ventricular fibrillation with epinephrine

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 2, 1998, Pages 373-382

  Tovar, Oscar H ^a,b   Bransford, Paris P ^a   Jones, Janice L ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Action potential duration; Catecholamines; Epinephrine; Fibrillation cycle length; Spontaneous defibrillation; Ventricular fibrillation; Ventricular fibrillation probability; Ventricular fibrillation threshold

Indexed keywords

ADRENALIN;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; FEMALE; HEART PACING; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINUS RHYTHM;

EID: 0032006607     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0600     Document Type: Article

References (26)

1. ATTWELL D, COHEN I, EISNER DA, 1981. The effects of heart rate on the action potential of guinea-pig and human ventricular muscle. J Physiol (London) 313: 439-461.
2. BERTEL O, BÜ FR, BAITSCH G, RITZ R, BURKART F, 1982. Plasma adrenaline and noradrenaline in patients with acute myocardial infarction. Relationship to ventricular arrhythmias of varying severity. Chest 82: 64-68.
3. CLAYTON RH, MURRAY A, HIGHAM PD, CAMPBELL RW, 1993. Self-terminating ventricular tachyarrhythmias - a diagnostic dilemma? The Lancet 341: 93-95.
4. DANILO P, VULLIEMOZ Y, VEROSKY M, ROSEN MR, 1978. Epinephrine-induced automaticity of canine cardiac purkinje fibers and its relationship to the adenylate cyclase-adenosine 3′,5′-monophosphate system. J Pharmacol Exp Ther 205: 175-182.
5. HAN J, DE JALON P, MOE GK, 1964. Adrenergic effects on ventricular vulnerability. Circ Res 16: 516-524.
6. JAKOB H, NAWRATH H, RUPP J, 1988. Adrenoceptor-mediated changes of action potential and force of contraction in human ventricular heart muscle. Br J Pharmacol 94: 584-590.
7. JONES JL, SWARTZ JF, JONES RE, 1990. Increasing fibrillation duration enhances relative assymmetrical biphasic versus monophasic defibrillator waveform efficacy. Circ Res 67: 376-384.
8. JOSEPHSON ME, SPIELMAN SR, GREENSPAN AM, HOROWITZ LN, 1979. Mechanism of ventricular fibrillation in man. Observations based on electrode catheter recordings. Am J Cardiol 44: 623-631.
9. LITTLE RA, FRAYN KN, RANDALL PE, STONER HB, YATES DW, LAING GS, KUMAR S, BANKS JM, 1985. Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Quart J Med 54: 133-140.
10. MANOACH M, BASAT MB, 1990. The structural-functional basis of spontaneous ventricular defibrillation. Int J of Cardiol 26: 129-136.
11. MEREDITH IT, BROUGHTON A, JENNINGS GL, ESLER MD, 1991. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325: 618-624.
12. MOE GK, RHEINBOLD WC, ABILDSKOV JA, 1964. A computer model of atrial fibrillation. Am Heart J 67: 200-220.
13. MURNAGHAN MF, 1975. The effect of sympathomimetic amines on the ventricular fibrillation threshold in the rabbit isolated heart. Br J Pharmacol 53: 3-9.
14. OPIE LH, LUBBE WF, 1979. Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade. S Afr Med J 56: 871-880.
15. PAPP JG, SZEKERES L, 1968a. Analysis of the mechanism of adrenergic actions on ventricular vulnerability. Euro J of Pharmacol 3: 15-26.
16. PAPP JG, SZEKERES L, 1968b. The arrhythmogenic action of sympathomimetic amines. Eur J of Pharmacol 3: 4-16.
17. PEUHKURINEN KJ, HUIKURI HV, LINNALUOTO M, TAKKUNEN JT. 1994. Changes in myocardial metabolism and transcardiac electrolytes during simulated ventricular tachycardia: effects of beta-adrenergic blockade. Am Heart J 128: 96-105.
18. POSEL D, NOAKES T, KANTOR P, 1989. Exercise training after experimental myocardial infarction increases the ventricular fibrillation threshold before and after the onset of reinfarction in the isolated rat heart. Circulation 80: 138-145.
19. SCHWARTZ PJ, VERRIER RL, LOWN B, 1977. Effect of stellectomy and vagotomy on ventricular refractoriness in dogs. Circ Res 40: 536-540.
20. SMEETS JL, ALLESSIE MA, LAMMERS WJ, BONKE FI, HOLLEN J, 1986. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res 73: 96-108.
21. SWARTZ JF, JONES JL, FLETCHER R, 1993. Characterization of ventricular fibrillation based on monophasic action potential morphology in the human heart. Circulation 87: 1907-1914.
22. TAGGART P, SUTTON P, LAB M, DEAN J, 1990. Interplay between adrenaline and interbeat interval on ventricular repolarization in intact heart in vivo. Cardiovasc Res 24: 884-895.
23. TOVAR OH, JONES JL, 1997. Epinephrine facilitates cardiac fibrillation by shortening action potential refractoriness. J Mol Cell Cardiol 29: 1447-1455.
24. VODANOVIC S, TURNER LA, HOFFMANN RG, KAMPINE JP, BOSNJAK ZJ, 1993. Transient negative dromotropic effects of catecholamines on canine purkinje fibers exposed to halothane and isoflurane. Anesth Analg 76: 592-597.
25. WEST TC, LAUD JF, 1962. Minimal mass required for induction of a sustained arrhythmia in isolated atrial segment. Am J Physiol 202: 232-236.
26. WIGGER CJ, 1929. Studies of ventricular fibrillation caused by electrical shock. Am Heart J 5: 351-365.